Business Wire

THE-PENINSULA-HOTELS

9.2.2021 07:02:26 CET | Business Wire | Press release

Share
1954 Ferrari 750 Monza Wins the Peninsula Classics 2020 Best of the Best Award

The Peninsula Hotels, whose international hospitality brand has epitomised glamour and luxury for nearly a century, today announced the winner of its sixth annual classic car showcase, The Peninsula Classics 2020 Best of the Best Award. The winning car, the 1954 Ferrari 750 Monza, coachwork by Scaglietti , has achieved distinction both for its impressive racing history and its exacting restoration. It became eligible as a Best of the Best Award contender after winning Best of Show at the 2020 Palm Beach Cavallino Classic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005295/en/

The Best of the Best Award was co-founded in 2015 by The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited (owner and operator of The Peninsula Hotels), along with William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. The Award celebrates the fine engineering and design of classic cars built by internationally renowned manufacturers, selected from an exceptional short list of winners from the most exclusive concours. This year’s award has a contracted list of nominees due to cancellation or postponement of partner concours in 2020 as a result of the COVID-19.

The 1954 Ferrari 750 Monza was chosen from a selection of four nominees crafted by automakers from Italy, Germany, and the United States, including a 1969 Porsche 917 KH Coupé, coachwork by the Factory, 2020 Best of Show, Concours of Elegance Hampton Court Palace, 1931 Alfa Romeo 8C 2300 Monza Spider, coachwork by Zagato, 2020 Best of Show, Salon Privé and a 1929 Duesenberg Model J Town Limousine, coachwork by Murphy, 2020 Best of Show, Amelia Island Concours d’Elegance.

The winner was selected by The Best of the Best Award’s esteemed panel of judges, including, amongst others, designers Gordon Murray (former Formula 1 designer for Brabham and McLaren) and Anne Asensio (Vice President of Design Experience at Dassault Systèmes), and prominent classic car collectors Laurence Graff and Jay Leno.

“It was a difficult task for our judges to select a winner this year. Our judging procedures had to be carried out remotely and unfortunately the main awards event had to be cancelled, with social distancing measures and safety our top priority,” said The Hon. Sir Michael Kadoorie. “With such a prestigious collection of nominees, choosing one winner was especially challenging. However, it is always a great pleasure to spotlight the remarkable achievements of the automotive industry, and to create a small spark of joy in the current challenging times. These classic vehicles are an enduring testament to human artistry and ingenuity.”

The winning 750 Monza made its original debut with a 2-litre motor at the Inaugural Grand Prix of the Imola Autodrome in June of 1954. After driver Umberto Maglioli secured first place for Scuderia Ferrari with the car, it was subsequently fitted with a 3-litre engine and went on to compete in several other major races that year, including the Monsanto Grand Prix (where it won), and Nassau Race Week – where it was driven by its original owner, Alfonso de Portago, and secured a 1st and two 2nd places.

The car’s next owner, Sterling Edwards, raced the 750 Monza over the next two years mainly in California, including the Pebble Beach Road Races (an event he founded) in 1955 and 1956 – garnering four 1st-place and two first-in-class wins in the car. After the tragic death of his friend Ernie McAfee prompted Edwards to stop racing altogether, he sold the car to his engineer Bob Whitmer, who replaced its engine with a Chevy V8 and continued to successfully race it through the early 1960s.

The car spent most of the ensuing 50 years disassembled, though its chassis, body, engine, and gearbox were all carefully preserved in a small San Francisco-area warehouse. In 2016, a complete restoration of the car was initiated under the direction of Bob Smith Coachworks, located in Gainesville, Texas, a process that took new owners Tom and Jill Peck of southern California over two years to complete.

The refurbishment was guided by several noted Ferrari historians: Marcel Massini of Switzerland, Alan Boe of Braselton, Georgia, David Seielstad of Hawaii, as well as past owners Sterling Edwards’ son Hammond and Bob Whitmer, both from northern California. The vintage certification team at Ferrari Classiche in Maranello, Italy, was also helpful in piecing together the early racing career of the car while campaigned by Ferrari. Bringing their combined wealth of knowledge to the project, these experts employed many of the vehicle’s preserved original documents and instruments, including the original owners’ manual, toolboxes, build sheets, and a treasure trove of original photographs of the car. Computer modelling of these photos was employed to repair flaws in the body from the car’s racing days, and 3-D printing technology was utilised to duplicate some parts that were irreparable. The vehicle’s livery was restored to that which it sported in its first Carrera Panamericana race in 1954.

Once fully restored, the 1954 Ferrari 750 Monza won the Enzo Ferrari Award at the 2019 Pebble Beach Concours d’Elegance and 2020 Best of Show at the Cavallino Classic, before being named winner of The Peninsula Classics 2020 Best of the Best Award.

“It is a true honour to be recognised by the venerable judges of The Peninsula Classics,” said Mr. Peck of his car’s latest success. “Like so many classic cars, this one has been both a labour of love and the product of dedicated teamwork. The Best of the Best Award is a crowning achievement for everyone involved.”

About The Peninsula Classics Best of the Best Award

Through a shared desire to celebrate the best of what defines the automotive world, The Hon. Sir Michael Kadoorie, Chairman of The Hongkong and Shanghai Hotels, Limited, launched The Peninsula Classics Best of the Best Award in 2015 with co-founders William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. Each founder shares a common passion and appreciation of fine motor cars, the preservation of their heritage and immaculate restoration projects. The award, sponsored by The Peninsula Hotels , brings together elite ‘Best of Show’ winners from nine of the renown concours circuits around the globe: Amelia Island Concours d’Elegance, Cavallino Classic, Chantilly Arts & Elegance Richard Mille, Concorso d’Eleganza Villa d’Este, Concours of Elegance Hampton Court Palace, Goodwood Cartier Style et Luxe Concours d’Elegance, Pebble Beach Concours d’Elegance, Salon Privé, and The Quail, A Motorsports Gathering.

Link:

ClickThru

Social Media:

https://www.facebook.com/ThePeninsulaHotels

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye